Evidence map›Paper›PMID 32611204›Full record

ArticleCirculation. Heart failure2020

Natriuretic Peptides, Inflammation, and Sounding the Alarm.

Vijay Ramakrishnan, John C Burnett

Abstract readEditorialComment
In one paragraph

Article in Circulation. Heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Clinical Insights from Proteomics in Heart Failure.Current heart failure reports · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Vijay RamakrishnanCardiorenal Research Laboratory, Department of Cardiovascular Medicine (V.R., J.C.B.), Mayo Clinic, Rochester, MN.
John C BurnettCardiorenal Research Laboratory, Department of Cardiovascular Medicine (V.R., J.C.B.), Mayo Clinic, Rochester, MN.

Funding

Novel Peptide Therapeutics for HypertensionR01HL136340 · NHLBI · MAYO CLINIC ROCHESTER · PI BURNETT, JOHN C · 2018 to 2021
$2.5M
Novel Peptide Therapeutics for Cardiorenal Protection in Heart FailureR01HL134668 · NHLBI · MAYO CLINIC ROCHESTER · PI BURNETT, JOHN C · 2017 to 2020
$1.6M
NHLBI NIH HHS R01 HL134668NHLBI NIH HHS R01 HL136340
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart FailureHumansInflammationNatriuresisNatriuretic PeptidesVasodilator AgentsNatriuretic PeptidesVasodilator Agentscytokineseditorialsendothelial cellsinflammationnatriuresispeptides

Identifiers

PMID32611204
PMCPMC7518514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.